Edition:
India

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

46.78EUR
16 Jul 2019
Change (% chg)

€-0.03 (-0.05%)
Prev Close
€46.80
Open
€46.80
Day's High
€47.40
Day's Low
€46.78
Volume
1,220,229
Avg. Vol
1,634,076
52-wk High
€71.00
52-wk Low
€38.28

Select another date:

Wed, Jun 5 2019

Photo

Fresenius says tighter EU rules could trigger antibiotic shortage

FRANKFURT German drugmaker Fresenius warned that stricter production norms being considered by Europe's drug regulator could compound shortages of a life-saving antibiotic that is used by about 25 million patients globally each year.

Fresenius says tighter EU rules could trigger antibiotic shortage

FRANKFURT German drugmaker Fresenius warned that stricter production norms being considered by Europe's drug regulator could compound shortages of a life-saving antibiotic that is used by about 25 million patients globally each year.

Fresenius says tighter EU rules could trigger antibiotic shortage

* Regulator EMA working on revision of manufacturing guidelines

Fresenius CEO: Don't see us making any large acquisitions this year

BERLIN German healthcare group Fresenius probably will not make any large acquisitions this year, the group's chief executive officer said on Friday, adding that this was more likely from next year.

Fresenius CEO: Don't see us making any large acquisitions this year

BERLIN, May 17 German healthcare group Fresenius probably will not make any large acquisitions this year, the group's chief executive officer said on Friday, adding that this was more likely from next year.

Fresenius talking to potential suitors about sale of blood transfusion business - sources

FRANKFURT Fresenius has approached potential suitors about the sale of its blood transfusion business, two people with knowledge of the matter said on Friday.

UPDATE 1-Fresenius talking to potential suitors about sale of blood transfusion business - sources

* Fresenius has hired Goldman Sachs for potential sale - sources

Fresenius talking to potential suitors about sale of blood transfusion business - sources

FRANKFURT, May 10 Fresenius has approached potential suitors about the sale of its blood transfusion business, two people with knowledge of the matter said on Friday.

UPDATE 2-Fresenius makes solid start to year after turbulent 2018

* Confirms full-year guidance (Adds analysts, shares, details)

Fresenius makes solid start to Q1 after troubled 2018

BERLIN, May 2 Fresenius reported a quarter of solid sales and earnings growth on Thursday helped by its generic infusion drugs and dialysis units and signs of stabilisation at its troubled German hospital business.

Select another date: